Katz, Eva G.

Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma

Voorhees, Peter M. , Cohen, Yaël C. , Lindsay, Jindriska, Baker, Ross , Suzuki, Kenshi , Kosugi, Hiroshi , Beksac, Meral, Garate, Gonzalo, Theunissen, Koen, Mylin, Anne K., Bringhen, Sara, Uttervall, Katarina , Medvedova, Eva , Cowan, Andrew J. , Mateos, María‐Victoria , Goldschmidt, Hartmut , Ahmadi, Tahamtan , Sha, Linlin, Cortoos, Annelore, Katz, Eva G. , Rousseau, Els, Dennis, Robyn M., Carson, Robin, Beksaç, Meral , Pianko, Matthew J. , Beksac, Meral , Baker, Ross Ian , Dimopoulos, Meletios Α. , Schjesvold, Fredrik , Hungria, Vânia , Sandhu, Irwindeep , Levin, Mark-David , Stockerl‐Goldstein, Keith , Oriol, Albert , Mikala, Gábor , Špıčka, Ivan , Bringhen, Sara, Puła, Bartosz , Moreau, Philippe, Li, Liang , Rajkumar, S. Vincent

New England Journal of Medicine | December 9, 2024 | Volume: 392 | Issue: 18 | Pages: 1777-1788

10.1056/nejmoa2409029